BLPH

Bellerophon Therapeutics (BLPH)

Bellerophon Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:BLPH

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/01/30	23 : 29	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BLPH	Bellerophon Therapeutics Inc
2024/01/27	04 : 31	Edgar (US Regulatory)	Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:BLPH	Bellerophon Therapeutics Inc
2024/01/27	00 : 46	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:BLPH	Bellerophon Therapeutics Inc
2024/01/23	05 : 21	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BLPH	Bellerophon Therapeutics Inc
2024/01/11	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BLPH	Bellerophon Therapeutics Inc
2024/01/04	03 : 49	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:BLPH	Bellerophon Therapeutics Inc
2023/10/27	23 : 50	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:BLPH	Bellerophon Therapeutics Inc
2023/10/17	09 : 51	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BLPH	Bellerophon Therapeutics Inc
2023/10/17	02 : 59	Edgar (US Regulatory)	Form RW - Registration Withdrawal Request	NASDAQ:BLPH	Bellerophon Therapeutics Inc
2023/10/17	02 : 59	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:BLPH	Bellerophon Therapeutics Inc
2023/10/17	02 : 58	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:BLPH	Bellerophon Therapeutics Inc
2023/10/17	02 : 58	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:BLPH	Bellerophon Therapeutics Inc
2023/10/17	02 : 57	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:BLPH	Bellerophon Therapeutics Inc
2023/10/17	02 : 56	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:BLPH	Bellerophon Therapeutics Inc
2023/10/17	02 : 56	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:BLPH	Bellerophon Therapeutics Inc
2023/10/17	02 : 55	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:BLPH	Bellerophon Therapeutics Inc
2023/10/17	02 : 54	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:BLPH	Bellerophon Therapeutics Inc
2023/10/13	23 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BLPH	Bellerophon Therapeutics Inc
2023/10/13	21 : 45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BLPH	Bellerophon Therapeutics Inc
2023/08/15	05 : 30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:BLPH	Bellerophon Therapeutics Inc
2023/08/08	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BLPH	Bellerophon Therapeutics Inc
2023/07/25	05 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BLPH	Bellerophon Therapeutics Inc
2023/07/21	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BLPH	Bellerophon Therapeutics Inc
2023/07/15	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BLPH	Bellerophon Therapeutics Inc
2023/06/30	05 : 06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BLPH	Bellerophon Therapeutics Inc
2023/06/30	05 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BLPH	Bellerophon Therapeutics Inc
2023/06/12	19 : 45	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:BLPH	Bellerophon Therapeutics Inc
2023/06/10	05 : 13	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BLPH	Bellerophon Therapeutics Inc
2023/06/10	05 : 12	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BLPH	Bellerophon Therapeutics Inc
2023/06/10	05 : 12	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BLPH	Bellerophon Therapeutics Inc